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Morbidity of total pancreatectomy with islet cell auto-transplantation
compared to total pancreatectomy alone
Islet Auto-transplantation: When Theory Collides with Reality
While effective, total pancreatectomy (TP) is a last resort therapy for patients with refractory chronic pancreatitis.
To mitigate the debilitating endocrinopathy guaranteed to follow, pancreatic islet cell auto-transplantation (IAT)
has been combined with TP in some. Though appealing in theory, IAT is resource intensive and quite challenging
for patients and their caregivers. This is clarified by Bhayani et al. whomined 6 years of the nationwide prospective
clinical NSQIP database to compare near-term perioperative outcomes between TP alone (n = 126) and TP-IAT
combined (n = 191). Most (77%) underwent operation for chronic pancreatitis. The primary outcome of major
morbidity occurred in 36%. Patients undergoing TP-IAT were decidedly younger, healthier and maintained their
weight better than TP patients. Despite this apparent clinical advantage, TP-IAT patients endured a 50% higher
rate of major morbidity, more transfusions, and significantly longer lengths of hospital stay. The authors discuss
these outcomes in terms of technical (later vascular disconnection, systemic anticoagulation) and clinical (tran-
sient hepatic insufficiency, portal hypertension) elements unique to IAT. There were no differences in mortality,
likely related to an age/health selection bias. While absent long term outcomes, this study can be used to frame
discussions with patients as to the significant risks associated with TP-IAT.
Mark Callery
What drives altruism in living liver donors – a risk-decision analysis?
Living organ donation is unusual in medical practice because for the donor there is a significant health risk
incurred through donation which is only offset by a sense of well being from helping another human who is in
clinical need. In his contemporary analysis of Darwinist theory, ‘The Selfish Gene’ Richard Dawkins explains
altruism in terms of protecting lines of inheritance and in this analysis he questions the illogicality of altruistic acts
outside of this framework. This issue of HPB contains an analysis by Molinari and colleagues of the drivers for
living liver donors to donate. The paper acknowledges the balance between risk and benefit and there is a several
log order increased risk of serious harm or death to otherwise healthy individuals compared with for example
living kidney donation.Molinari et al. did find that altruismwasn’t given completely freely.Apart from the obvious
need for a biological or close emotional relationship between donor and recipient, donors had an expectation of
reasonable prospects of survival for the recipient at one and 3 years. Donors were likely to donate if there was an
expectation that the recipient would have a protracted wait for a cadaveric graft. Interestingly donors were
prepared to accept a greater level of risk than clinicians. This study provides an important insight into the
decision-making processes of potential liver donors. The authors conclude that living donors are ‘risk takers’, while
this may be true, the risks are calculated and the donors in this study seemed well equipped to make the decisions
underpinning the risk.
Stephen J Wigmore
What to do with focal nodular hyperplasia (FNH)?
The explosion in the use of ultrasound and CT in medicine has resulted in the ‘incidentaloma’ becoming a
common reason for referral to an HPB surgeon. In this issue of HPB, Navarro et al. present a well performed
systematic review aiming to understand how FNH should be managed. Most HPB surgeons would feel that that
MRI with dedicated hepatic contrast agents should be the minimum standard for assessment of a lesion detected
incidentally. This belief is reinforced from the results of this review which showed MRI to be vastly superior to
other modalities when diagnosing FNH. What was however was surprising was the number of studies in which
MRI was not the minimum standard of investigation. In addition, little data were provided about the level of
radiological expertise in reporting these lesions. It would be many HPB surgeons experience that this would be a
significant factor that alters the level of radiological diagnostic certainty. In those lesions that remain indetermi-
nant after optimal imaging, does a percutaneous biopsy provide the answer? It would appear that this still has a
significant risk of diagnostic error so caution is required in interpretation. In addition, any planned biopsy should
aim to minimise track seeding should a malignant lesion be proven. The indications for surgery were reviewed as
were subsequent outcomes. Surgery can be performed with an ‘acceptable morbidity’ and mortality would appear
to be extremely rare. However is surgery ever indicated? The number requiring surgery for diagnostic uncertainty
should be decreasing but what about ‘symptomatic patients’. For those who were deemed symptomatic the low
level of evidence available did suggest that symptoms resolved post resection. It should also be recognised that high
rates of spontaneous symptom resolution have also occurred in patients managed conservatively. Therefore the
true value of surgery for FNH remains unknown.
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